Identification of ß-nerve growth factor in dromedary camel seminal plasma and its role in induction of ovulation in females by Fatnassi, Meriem et al.
Emir. J. Food Agric ● Vol 29 ● Issue 4 ● 2017 293
Identification of β-nerve growth factor in dromedary 
camel seminal plasma and its role in induction of 
ovulation in females
Fatnassi Meriem1,2, Cebrián-Pérez José Alvaro3, Salhi Imed1, Pérez-Pé Rosaura3, Seddik Mabrouk Mouldi1, 
Casao Adriana3, Khorchani Touhami1, Muiño-Blanco Teresa3, Hammadi Mohamed1*
1Livestock and Wildlife Laboratory, Arid Lands Institute, 4100 Médenine, University of Gabès, Tunisia, 2Higher Institute of Agricultural Science 
of Chott-Mariem, 4042 Chott-Mariem (Sousse), Tunisia, 3Department of Biochemistry and Molecular and Cell Biology, IUCA, School of 
Veterinary Medicine, University of Zaragoza-IUCA, Zaragoza, Spain
INTRODUCTION
Ovulation in mammals is controlled by a complex neuro-
endocrine mechanism including signalling pathways 
connecting the reproductive organs and the brain. 
Mammalian species have been classified as either induced 
or spontaneous ovulators, depending on the stimulation 
system of  GnRH release from the hypothalamus (Bakker 
and Baum, 2000). Camelids are considered induced-
ovulatory species, given that the preovulatory LH surge can 
take place after natural coitus (Marie and Anouassi, 1986; 
Hammadi, 2003) or intramuscular injection of  seminal 
plasma (SP) (Pan et al., 2001; Ratto et al., 2005).
The evidence of  an ovulation inducing factor (OIF) has 
been firstly reported in SP of  Bactrian camels (Chen 
et al., 1985; Pan et al., 2001) and ovulation occurred after 
intravaginal or intramuscular/intrauterine administration 
of  SP to female Bactrian camels (Zhao et al., 2001; Li 
and Zhao, 2004). Following studies demonstrated also 
the presence of  this factor in SP of  llamas (Adams et al., 
2005; Ratto et al., 2012; Silva et al., 2014) and alpacas 
(Ratto et al., 2005; Kershaw-Young et al., 2012). In llamas, 
OIF was described as a protein with a molecular weight 
of  approximately 14 kDa that displays a potent ovulatory 
effect, resistant to heat-shock and enzymatic digestion with 
proteinase (Ratto et al., 2010; Ratto et al., 2011). In fact, 
the intramuscular administration of  this protein factor 
provokes ovulation via the release of  a preovulatory LH 
surge, suggesting an endocrine effect at the central level 
of  the hypothalamic-pituitary axis (Adams et al., 2005; 
Ratto et al., 2011; Ulloa-Leal et al., 2014). More recent, 
a proteomic study revealed that OIF from llama has a 
molecular mass of  13.221 kDa, and a database search 
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showed that the 12–23 amino-acid sequence of  OIF had a 
high homology with the sequence of  the β-Nerve Growth 
Factor (β-NGF) of  human, porcine, bovine and murine 
species (Ratto et al., 2012). The isolation and identification 
of  β-NGF from dromedary camel seminal plasma was 
conducted by Kumar et al. (2013), who showed that this 
factor has a molecular mass of  22 kDa with a MASCOT 
score of  118 and 2 matched peptides. However, the 
ovulation inducing capacity of  dromedary camel β-NGF 
has not been demonstrated. Taking into account the known 
effects of  OIF/β-NGF in camelids species (Pan et al., 1992; 
Ratto et al., 2011; Kershaw-Young et al., 2012; Berland 
et al., 2016), we hypothesized that OIF/β-NGF from 
dromedary camel seminal plasma might induce ovulation 
and provoke an increase in the progesterone concentration. 
Therefore, the aim of  the present study was to purify 
and evaluate the ovulatory effect of  the intramuscular 




The study was carried outat the Arid Lands Institute’s 
experimental station in Médenine, Tunisia (33° 30′ N, 
10° 40′ E and 18 m above sea level).The procedures were 
performed according to the protocols of  the Tunisian 
Ministry of  the Higher Education and Scientific Research 
in accordence with EC regulations.
Males
Six clinically healthy male dromedary camels, ranging in age 
from 6 to 17 years, with a mean body weight of  545 ± 63 kg 
and good body condition score (3.8 ± 0.7 arbitrary units 
from 0 to 5, according to Faye et al., 2001) were used for 
semen collection. The camels were managed as previously 
described (Fatnassi et al., 2014).
Females
A total of  16 non-lactating and fertile female camels aged 
between 7 and 20 years and having a 419 ± 41 kg body 
weight were used from March to April 2015. Dams were 
kept in pen and daily moved to salty pastureduring 6 to 
7 h and providedsupplementary barely straw, concentrate 
(crude protein 11%, ash 8%, neutral detergent fiber 32%), 
and water once a day.
Seminal plasma preparation
Semen was collected twice a week during December 
to March using a bovine artificial vagina and a 
female camel maintained in a couched position. 
After collection, ejaculates were kept in a water bath 
(36°C) until liquefaction (60-180 min). Used ejaculates 
were characterized by volume = 10.6 ± 7.3 ml, mass 
motility = 2.8 ± 1.1 (score 0 – 5), viability = 56.4 ± 
10.6% and concentration = 686.6 ± 375.5 × 106 spz/ml. 
To obtain seminal plasma, semen samples were subjected 
to 2 successive washings by centrifugation at 10.000 g 
for 10 min, at room temperature (RT). The protein 
concentration of  seminal plasma was measured by 
spectrophotometry (Biuret method) and samples 
containing more than 12 mg/ml were pooled and stored 
at -80 °C until use in further assays.
Seminal plasma protein purification
The protein purification procedure was performed 
according to the process described by Ratto et al. (2011). In 
brief, 2 ml (35-40 mg of  protein) of  camel seminal plasma 
was fractionated by fast protein liquid chromatography 
(FPLC, GE Healthcare Life Sciences, Bjorkgatan, 
Sweden) using a gel filtration column (SEC, Hi PrepTM 
26/60 SephacrylTMS-100, GE Healthcare Life Sciences, 
Bjorkgatan, Sweden). The purification was carried out at RT 
at a flow rate of  0.5 ml/min and the elution was performed 
isocratically using phosphate buffered saline (PBS) at 
pH 7.4 as a mobile phase. The eluate was collected in 2 ml 
fractions and the absorbance at 280 nm was measured with 
a UV 280 detector. In these conditions, two protein peaks 
were obtained and corresponding fractions were pooled 
separately and stored at -20°C until utilization.
SDS PAGE and densitometry quantification
The pools of  the two isolated peaks were concentrated 
using ultra-filters (Amicon® Ultra-15 Centrifugal Filter 
Devices, Merck Millipore Corporation, Darmstadt, 
Germany) with a nominal molecular weight limit of  
3.0 kDa. Protein concentration was measured using the 
Bradford method (1976).Whole dromedary camel seminal 
plasma (CSP) and the two isolated fractions (P1 and P2) 
were analysed before loading onto polyacrylamide gels.
SDS–PAGE electrophoresis was carried out according to 
Laemmli (1970). Briefly, protein band profiles in CSP, P1 
and P2 were examined by 14% polyacrylamide gels under 
denaturing conditions after loading 5 µg of  protein of  each 
sample. Electrophoresis was performed at 130 V and 4 °C 
for 90 min. A mixture of  pre-stained molecular weights 
ranging from 10 to 250 kDa (Bio-Rad, Hercules, CA, USA) 
was used as a standard marker. Proteins were stained with 
Coomassie blue stain (R-250, Serva, Heidelberg, Germany). 
Gels were imaged with the Odyssey Infrared Imaging 
system (Odyssey®, LI-COR Biosciences, Lincoln, USA) 
in the 700 nm channel. Densitometry quantification of  the 
protein bands present in the gel was performed using the 
publicly available ImageJ software (IJ 1.50b) in accordance 
with published guidelines (Ferreira and Rasband, 2012).
Meriem, et al.: Camel β-NGF induces ovulation in dromedary female
Emir. J. Food Agric ● Vol 29 ● Issue 4 ● 2017 295
Western blot
The beta nerve growth factor (β-NGF) was detected by 
western blot according to the protocol used by Druart 
et al. (2013) with some modifications. Five µg of  protein 
from CSP, P1 and P2 was loaded on each lane of  14% 
polyacrylamide gel. A recombinant Human β-NGF 
(Gibco®, Life technologies™, New York,USA) was 
also loaded onto the gel as a positive control. Separated 
proteins were transferred onto an Immobilon-PVDF 
transfer membrane (midi format, 0.2 µm PVDF, Transfer 
Pack, Bio-Rad, Hercules, CA, USA) and blotted using the 
Trans Blot®Turbo™ blotting system (Bio-Rad, Hercules, 
CA, USA) at a constant 2.5 A up to 25 V for 10 min. 
After transference, the membranes were blocked with 
5% BSA dissolved in PBS for 2 h at RT under shaking. 
Then, β-NGF was detected by incubating the membrane 
with rabbit polyclonal antibody raised against human 
NGF (NGF (H-20): sc-548, Santa Cruz Biotechnology, 
INC, Heidelberg, Germany), diluted 1/1,000,000 (v/v) 
in phosphate buffered saline with 0.1 % (v/v) Tween 20 
(PBST) and 1% (w/v) BSA, under mild agitation overnight 
at 4 °C. Following incubation with the primary antibody, the 
blotting membrane was washed three times for 15 min with 
PBST. A secondary antibody IRDye® 800 CW donkey anti 
rabbit (LI-COR® Biosciences, Lincoln, USA) was diluted 
in PBST with 1% BSA (1/100,000 v/v) and the membrane 
was incubated for 1 h and 15 min at RT. After incubation 
with the secondary antibody, the membrane was washed 
again and revealed using Odyssey (Odyssey®, LI-COR 
Biosciences, Lincoln, USA) in the 700 and 800 nm channels.
Synchronization of females and treatments
Female camels were subjected to estrus synchronization 
protocol according to Skidmore et al. (2009) with 
modification. Brief ly, each female was injected 
intramuscularly (i.m.) on day 0 with 500 µg cloprostenol, 
a prostaglandin analogue (Estrumate, Essex Animal 
Health Friesoythe, Germany) to remove any existing 
corpus luteum from the ovaries, followed by 20 µg of  
Buserelin, a GnRH analogue (i.m, Receptal, Intervet, 
Beaucouze Cedex, France) 7 days later to induce 
ovulation and synchronize the emergence of  the next 
follicular wave. Fourteen days after the GnRH analogue 
injection, the synchronized camels were divided into four 
groups, and each group was then randomly assigned to 
treatments.
In the light of  previous studies that reported an ovulatory 
response above 90% using 1mg of  either llama or alpaca 
β-NGF (Ulloa-Leal et al., 2014; Stuart et al., 2014), a dose 
of  1 mg of  P2/Cam-β-NGF was used. Furthermore, we 
also tested a dose of  2 mg of  P2/Cam-β-NGF based on 
the body weight of  female dromedary camel compared to 
llama and alpaca females.
The IM doses were as follows:
• Group1: 1ml PBS (negative control group; n = 3)
• Group 2: 20 µg Buserelin (GnRH analogue, positive 
control group; n = 3)
• Group 3: 1mg Dromedary camel β-NGF (Cam-β-
NGF; n = 5)
• Group 4: 2mg Cam-β-NGF (n = 5).
Blood sampling and progesterone assays
Ovulation was defined as an increase in blood progesterone 
concentration above 1ng/ml during the 2nd period of  
luteal phase. For this, blood samples were taken on day 
0 (just before treatments) and every 2 days until day 14 
post treatment in order to measure plasmatic progesterone 
concentration. Blood was collected from the jugular vein 
into EDTA-tubes, centrifuged at  4 °C for 15 min at 1500 g, 
and the plasma was stored at -20 °C until analysis. The 
plasma progesterone concentration was assessed using a 
radio-immunoassay kit (Immunotech Ref  1188, Beckman 
Coulter, Marseille, France). Samples were analysed in 
duplicate with variation coefficients of  intra-and inter-
assays of  8.2 and 8.7%, respectively. The sensitivity of  the 
assay was 0.1 ng/ml.
Statistical analyses
Data of  plasma progesterone concentration were analysed 
by the NPAR1WAY procedure of  SAS (SAS 9.3, 2012) 
using Kruskal-Wallis test. The progesterone profile was 
divided into 3 phases in accordance with Marie and 
Anouassi (1987) (0-4 days, 6-10 days, 12-14 days) to test 
with accuracy the variation between the four treatments. 
The results were expressed as mean ± standard error and 
the P-level was set at 0.05.
RESULTS
Two protein peaks (P1 and P2) were detected after filtration 
of  the dromedary camel seminal plasma. The purification 
procedure was repeated twenty times, and very similar 
chromatograms were obtained under the same elution 
conditions (Fig. 1).
Protein profiles of  both whole dromedary camel seminal 
plasma (CSP) and the two isolated peaks (P1 and P2) 
obtained by SDS-PAGE (14%) under denaturing conditions 
are shown in Fig. 2A. A main protein band of  an 
approximate molecular weight of  14 kDa was identified 
in both CSP and P2. However, this protein band was 
present in a very low proportion in the first isolated peak 
(P1).Quantitatively, an ImageJ gel densitometry analysis 
estimated that the proportion of  the 14 kDa protein band 
in CSP was approximately 45% of  the total protein content 
and approximately 88% in P2.
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Western blot analysis allowed us to detect β-Nerve Growth 
Factor (β-NGF) in both CSP and the second peak (P2) 
isolated by FPLC (Fig. 2B). Recombinant Human β-NGF 
used as a positive control revealed a band about 14 kDa 
compatible with the predicted molecular weight for β-NGF.
The plasma progesterone profiles obtained in the four 
treatment groups are presented in Fig. 3. A significant effects 
of  the type of  treatment (ddl =3; χ² =24.63; P< 0.0001), and 
the days following treatment (ddl = 7; χ² = 56.60; P<0.0001) 
were found. The progesterone concentration increased 
significantly after IM injection of  Buserelin (P = 0.0046), 
1 mg (P = 0.0002) and 2 mg (P = 0.0017) of  Cam-β-NGF, 
whereas no significant difference was observed after PBS 
treatment (P = 0.5083). The rise in the plasma progesterone 
concentration took place from day 6 after treatment of  
females with either 1 mg of  Cam-β-NGF (5/5) or 2 mg of  
Cam-β-NGF (4/5), similar to the positive control group 
treated with Buserelin (3/3). However, this increase was not 
found in females treated with PBS (0/3), which showed a 
basal progesterone level (<1 ng/ml). In all treatment groups, 
the plasma progesterone concentration remained basal 
during the 4 first days post-treatment (Table 1). During the 
second phase (6-10 days), the progesterone concentration 
did not significantly differ between the Buserelin, 1 mg 
and 2 mg Cam-β-NGF groups, while the concentration 
in the PBS group was significantly lower than that of  the 
other three groups. During the third phase (12 - 14 days), 
the progesterone concentration returned to the basal level.
DISCUSSION
The present study is the first attempt to demonstrate the 
role of  the β-NGF purified from the seminal plasma of  
the dromedary camel as an in vivo ovulation-inducing factor 
operating by increasing the progesterone concentration. Two 
protein peaks were isolated from the seminal plasma using 
gel exclusion chromatography, similar to that previously 
reported for llama seminal plasma using a combination of  
hydroxyapatite and gel-filtration chromatography (Ratto 
et al., 2011). However, six protein fractions were obtained 
after separation of  Bactrian camel seminal plasma (Li and 
Zhao, 2004) and three protein peaks were eluted after 
purification of  dromedary camel seminal plasma using a 
sequential separation procedure (Kumar et al., 2013). The 
variability of  protein fractions could be explained by the 
differences in the purification procedures and the protein 
concentration in seminal plasma of  camelid species. In 
literature, protein concentration in seminal plasma averages 
22 mg/ml in Bactrian camel (Mosaferi et al., 2005), and ranges 
from 2.0 to 25.9 mg/ml in dromedary camel (El-Manna et al., 
1986; Hammadi et al., 2012; Vyas et al., 2014) and from 2.9 
to 43.6 mg/ml in alpaca (Stuart et al., 2014).
Similar to the result of  Ratto et al. (2011), an abundant 
protein having a molecular mass near to 14kDa was found 
in both CSP and P2 fraction, and identified as a β-NGF 
Table 1: Ovulation rates and variation of progesterone 









PBS 0% (0/3) 0.1±0.1 0.1±0.1b 0.1±0.1
Buserelin 100% (3/3) 0.2±0.1 3.2±0.6a 0.2±0.1
1 mg P2/Cam-β-NGF 100% (5/5) 0.2±0.1 3.0±0.5a 0.2±0.4
2 mg P2/Cam-β-NGF 80% (4/5) 0.4±0.1 3.3±0.5a* 0.2±0.4
Data are the mean±SE. Within columns, values with different superscript 
letters differ significantly (P<0.05). *: average value of ovulated animals 
in the group. (Phase 1: 0 – 4 days; Phase 2: 6 – 10 days, Phase 
3: 12 – 14 days) and treatment groups: PBS (n=3), Buserelin (n=3), 1 mg of 
P2/Cam-β‑NGF (n=5), 2 mg of P2/Cam‑β‑NGF (n=5)
Fig 1. Protein chromatography profile of dromedary camel seminal 
plasma obtained after purification by fast protein size‑exclusion liquid 
chromatography (FPLC).
Fig 2. (A) Representative SDS‑PAGE profiles of whole dromedary 
camel seminal plasma (CSP) proteins and the two peaks (P1 and 
P2) isolated by molecular exclusion chromatography. Identical 
protein amounts (5 μg) of CSP, P1 and P2 were loaded onto 14% 
polyacrylamide gels and separated under denaturing conditions. 
(B) Detection of β-Nerve Growth Factor (β-NGF) in camel seminal 
plasma (CSP) and the two isolated peaks (P1 and P2) by western 
blotting using a recombinant Human β-NGF as a positive control, and 
a rabbit anti-β‑NGF primary antibody.
A B
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by Western Blot. The proportion of  this protein in CSP 
was considerably higher than that found by Druart et al. 
(2013) in dromedary camel seminal plasma (24%) and 
comparable to that in alpaca (47%).Previous studies on 
small camelids showed that β-NGF is a 26 ~27 kDa 
homodimer that is reduced to 2 dimers of  approximately 
14 kDa under denaturing conditions (Kershaw-Young 
et al., 2012; Ratto et al., 2012).Although, a proteomic 
study conducted by Kumar et al. (2013) revealed a 22 kDa 
molecular mass of  β-NGF purified from dromedary 
camel seminal plasma.
The relevant effect of  Cam-β-NGF on inducing ovulation 
was confirmed by a significant rise in progesterone 
concentration. Indeed, the intramuscular injection of  
P2 fraction (Cam-β-NGF) produced a similar significant 
increase in plasma progesterone as Buserelin treatment. 
This is consistent with previous results relating to the 
injection of  seminal plasma in either llamas(Adams 
et al., 2005; Ratto et al., 2011; Ulloa-Leal et al., 2014) or 
alpacas (Adams et al., 2005; Kershaw-Young et al., 2012), 
which induced ovulation evoking a significant increase 
of  progesterone secretion. The increased progesterone 
concentration could be explained by the indirect Cam-β-
NGF action on the establishment of  corpus luteum.
The progesterone profile obtained after injection with 
Buserelin and 1 or 2 mg Cam-β-NGF was similar to the 
normal profile of  corpus luteum development following 
natural mating (Marie and Anouassi, 1987; Skidmore et al., 
1996; Hammadi, 2003) or ovulation induction treatment 
(Skidmore et al., 1996; Nagy et al., 2005). However, it 
was different to that of  luteinized follicles; progesterone 
concentration rose for a short period of  time and the 
regression started later and lasted longer (Skidmore et al., 
1996).
NGF is a neuropeptide involved in many functions such 
as ovulation in some mammals (Dissen et al., 1996). 
Naturally, the seminal plasma factor deposited in the 
uterine cavity reaches rapidly the systemic circulation to 
elicit the release of  LH. In the recent work of  Berland et al. 
(2016), it was demonstrated that circulation β-NGF level 
in llama increases within 15 min after mating with intact 
male or seminal plasma treatment and incites the release 
of  LH surge and ovulation. In absence of  seminal plasma 
(mating with urethro-male), systemic β-NGF concentration 
remains low and no ovulation occurs. All of  this confirms 
that ovulation in camelid species is provoked by semen-
derived chemical signals via neuroendocrine pathways 
(Berland et al., 2016). However, the exact route of  action 
of  the β-NGF on LH secretion is not clear; suggesting 
an action in the hypothalamus level would stimulate the 
GnRH secretion (Silva et al., 2011) or a direct effect on 
the anterior pituitary causing the release of  LH (Paolicchi 
et al., 1999; Bogle et al., 2012).
Concerning the dose response, it is clear that the IM 
injection of  1 mg P2/Cam-β-NGF induces ovulation in 
all treated dromedary camel. Referring to the 88% rate of  
Fig 3. Mean progesterone concentration in blood plasma (ng/ml) of female camels after intramuscular injection of (A) 1 ml of phosphate buffered 
saline (PBS, negative control; n = 3), (B) 20 µg Buserelin (GnRH analogue, positive control; n = 3), (C) 1 mg of P2/Cam‑β‑NGF (n = 5) or (D) 2 
mg of P2/Cam-β‑NGF (n = 5). Different superscript letters indicate significant difference (P<0.05).
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purity of  the β-NGF in P2, we can assume that the used 
quantity of  this peptide is equal to 880 µg. Comparable 
results were found using 1 mg of  a commercial NGF 
protein in alpacas (Stuart et al., 2014) and 1mg of  purified 
llamas seminal plasma (Ulloa-Leal et al., 2014). The dose 
2 mg P2/Cam-β-NGF used in the present study leads to 
similar results compared to 1 mg dose. Then, it is may be 
better in further works to test less than 1 mg of  purified 
Cam-β-NGF, giving that a low dose (125 µg) of  OIF/NGF 
induced ovulation in llamas (Tanco et al., 2011).
According to the ovulation rate (80 – 100 %) obtained in this 
study, it is clear that almost all females had growing follicles 
having a diameter between 0.9 and 1.9 cm (Skidmore et al., 
1996) in day 14 post treatment with GnRH. Under this 
range of  preovulatory follicle size, female camels respond 
in the same way to the ovulation induction treatments 
with either 20 µg of  Buserelin or 1 or 2 mg of  P2/β-NGF 
purified from dromedary camel seminal plasma, showing 
a very similar progesterone profiles. However, Silva et al. 
(2014) showed that llamas treated with 1mg of  purified 
OIF/NGF produced greater plasma progesterone at day 
8 compared to those treated with GnRH, irrespective to 
the pre-ovulatory follicle diameter at the time of  treatment.
In conclusion, the OIF is highly abundant in dromedary 
camel seminal plasma and was identified as a β-Nerve 
Growth Factor “Cam-β-NGF”. The results support our 
hypothesis that intramuscular administration of  Cam-β-
NGF induces ovulation at similar rates like GnRH. This 
study opens up interesting new perspectives for knowing 
the exact mechanism of  action of  this molecule on 
induction ovulation, and for assessing the ability of  OIF as 
a protocol for synchronizing the ovulation in this species. 
Additionally, the quantification of  β-NGF in seminal 
plasma and the relationship between its concentration and 
sperm quality deserve investigation.
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